ARWR vs CLOV · rev $829.4M vs rev $1.37B
Arrowhead Pharmaceuticals Inc (ARWR) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ARWR currently screens at market cap $10.59B. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ARWR and CLOV stock pages for the full models.
Not investment advice.